Gong Jing, Wang Nan, Bian Lihua, Wang Min, Ye Mingxia, Wen Na, Fu Meng, Fan Wensheng, Meng Yuanguang
Department of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Department of Obstetrics and Gynecology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China.
Oncol Lett. 2019 Aug;18(2):1815-1823. doi: 10.3892/ol.2019.10514. Epub 2019 Jun 21.
The current study aimed to evaluate the correlation between maximum standardized uptake value (SUV) and minimum apparent diffusion coefficient (ADC) of cervical cancer using an integrated F-fluorodeoxyglucose positron emission tomography/magnetic resonance (PET/MR) imaging system, and to determine the association with pathological prognostic factors. A total of 46 patients were pathologically diagnosed with cervical cancer and underwent PET/MR prior to surgery, including total hysterectomy, bilateral pelvic lymph node dissection or paraaortic lymph node dissection. The imaging biomarkers included the SUV and ADC The pathological prognostic factors were as follows: Tumor size, histological grade, International Federation of Gynecology and Obstetrics (FIGO) stage and lymph node metastasis. Pearson's correlation analysis was used to evaluate the correlation between imaging biomarkers and the tumor size and the Mann-Whitney U test analysis was used to evaluate the association between imaging biomarkers and pathological factors. The mean SUV was 11.1±8.7 (range, 3.16-51.6) and the mean ADC was 0.76±0.15×10 mm/s (range, 0.47-1.04×10 mm/s). The SUV had a significant negative correlation with the ADC (r=-0.700; P0.001). The SUV was significantly increased in patients with poorly differentiated tumors (P=0.001), patients with FIGO stage IIB (P=0.005) and the patients with lymph node metastasis (P=0.040). The ADC was significantly decreased in patients with poorly differentiated tumors (P0.001) and patients with FIGO stage IIB (P=0.017). Statistical analysis revealed no significant correlation between the tumor size and the SUV (r=0.286;P=0.054), or between the tumor size and the ADC (r=-0.231; P=0.122). Area under the curve (AUC) analysis revealed that SUV had a higher diagnostic value for lymph node metastasis (AUC=0.681) and FIGO staging (AUC=0.837) compared with ADC, whereas ADC had a higher diagnostic value for the grade of pathological differentiation (AUC=0.816) compared with SUV (AUC=0.788). The results of the current study demonstrated that there was a significant negative correlation between SUV and ADC, which were associated with prognostic factors.
本研究旨在使用集成的F-氟脱氧葡萄糖正电子发射断层扫描/磁共振(PET/MR)成像系统评估宫颈癌的最大标准化摄取值(SUV)与最小表观扩散系数(ADC)之间的相关性,并确定其与病理预后因素的关联。共有46例经病理诊断为宫颈癌的患者在手术前行PET/MR检查,包括全子宫切除术、双侧盆腔淋巴结清扫术或腹主动脉旁淋巴结清扫术。成像生物标志物包括SUV和ADC。病理预后因素如下:肿瘤大小、组织学分级、国际妇产科联盟(FIGO)分期和淋巴结转移。采用Pearson相关分析评估成像生物标志物与肿瘤大小之间的相关性,采用Mann-Whitney U检验分析评估成像生物标志物与病理因素之间的关联。平均SUV为11.1±8.7(范围3.16 - 51.6),平均ADC为0.76±0.15×10⁻³mm²/s(范围0.47 - 1.04×10⁻³mm²/s)。SUV与ADC呈显著负相关(r = -0.700;P < 0.001)。低分化肿瘤患者(P = 0.001)、FIGO IIB期患者(P = 0.005)和有淋巴结转移的患者(P = 0.040)的SUV显著升高。低分化肿瘤患者(P < 0.001)和FIGO IIB期患者(P = 0.017)的ADC显著降低。统计分析显示肿瘤大小与SUV之间无显著相关性(r = 0.286;P = 0.054),肿瘤大小与ADC之间也无显著相关性(r = -0.231;P = 0.122)。曲线下面积(AUC)分析显示,与ADC相比,SUV对淋巴结转移(AUC = 0.681)和FIGO分期(AUC = 0.837)具有更高的诊断价值,而与SUV(AUC = 0.788)相比,ADC对病理分化程度(AUC = 0.816)具有更高的诊断价值。本研究结果表明,SUV与ADC之间存在显著负相关,且它们与预后因素相关。